 225-236, 1989.] 
Richard W Bohannon
The most obvious, although by no means ubiquitous or sole, consequence of cerebrovascular accidents (stroke) is a predominantly unilateral muscle weakness.
1 Nevertheless, some educators and authors have been suggesting for years that the measurement of muscle strength is inappropriate (ie, invalid) in patients with stroke. During the same time, many researchers have used a variety of methods to measure the strength of patients with hemiparesis. In addition to providing a well-founded precedent for such measurements, the researchers have demonstrated a relationship between muscle strength and functional capacity and outcome. The purposes of this special communication are to 1) discuss the issue of weakness following brain lesions, 2) address a few of the specific concerns that have been voiced by opponents to the strength testing of patients with brain lesions, 3) provide an indication of the magnitude of the support and precedent that exists for muscle strength testing of these patients, and 4) present information that relates muscle strength to functional capacity and outcome.
Muscle Weakness Following Brain Lesions and Concerns About Its Measurement
Given the demonstrated relationship between cortical and pyramidal tract activity and muscle force production in primates,
2-6 muscle weakness should be an expected result of lesions affecting corticomotoneuron cells, their projections, and their targets. Paresis from brain lesions can be classified as resulting primarily from reduced agonist output or from antagonist subtraction. 7 Reduced-output paresis is a result of a decreased ability of the motoneuron pool to drive the motor units of a target agonist muscle. 7 This reduced output has been documented in stroke patients during specified muscular efforts [8] [9] [10] and during activities requiring patterns of muscular recruitment.
11,12 Reduced output apparently affects the number and type of motor units recruited and the frequency of motor unit recruitment.
8,9,13-15 Subtraction paresis results from resistive antagonist forces. 7 In acknowledging the reality of subtraction paresis, it is important to note that 1) antagonist restraint can occur when the antagonist is electrically inactive (because of the passive stiffness of the antago-nist) 12, [16] [17] [18] ; 2) active antagonist resistance is unusual during static or slow-speed force measurements 8, 19, 20 ; 3) active antagonist restraint is more likely during rapid and possibly reciprocal muscle contraction 20, 21 ; and 4) coactivation of antagonists can be, but is not always, a problem during functional activities. 11, [20] [21] [22] The presence of subtraction paresis is probably one of the greatest concerns of those who recommend against strength testing hemiparetic patients. Bobath states that muscle weakness is not real but relative to opposition by spastic antagonists. 23 The literature outlined in the paragraph above, however, does not indicate that antagonist restraint should be a major problem during static strength testing. Other concerns about strength testing patients with brain damage include issues relevant to the position of testing 23, 24 and issues relevant to muscular function during strength testing as compared with during other activities. In regard to position, the relative capacity of brain-damaged patients to activate their muscles in different positions may not be affected in the manner that therapists have come to believe. 25, 26 For example, Sjöström et al concluded that "placement of the legs within patterns believed to facilitate (0° knee position) or inhibit (90° knee position) extensor motoneurons did not give rise to systematic strength variations different from those of the control subjects." 25(p58 ) Bohannon similarly showed that patients with hemiparesis had comparable gravity-eliminated sitting-supine knee flexion torque ratios on the paretic and nonparetic sides. 26 Muscles no doubt function differently depending on the circumstances of their activation. For example, the quadriceps femoris muscles of a patient with hemiparesis may act quite differently when used to extend the knee of a seated subject than when used during a sit-to-stand maneuver. This fact notwithstanding, strength testing may still provide an indication of brain-damaged patients' capacity to activate a muscle group under a known set of circumstances.
Support and Precedent for Muscle Strength Testing
Despite the opposition that some have voiced for muscle strength testing in patients with intracranial lesions, [23] [24] some clinical scientists hold paresis as a major problem [27] [28] [29] Perhaps the most fundamental of findings related to muscle strength in brain-damaged patients is that measurements obtained at one point in time correlate with measurements obtained at a later time and with other motor indexes. This finding can be important when patients have questions such as, "Will I get my strength back?" Logigian et al found that final MMT scores were significantly correlated (r = .78, p < .01) with initial MMT scores in 42 patients undergoing rehabilitation. 45 Bohannon showed significant correlations (r = .56-.83) between initial and final force measurements obtained by hand-held dynamometry from 16 muscle groups of 38 hemiparetic patients. 55 Bohannon and Smith found similar relationships when upper extremity muscle strength deficits were compared between initial and final assessment in 58 stroke patients undergoing rehabilitation (r=.73-.85). 58 Smedley et al, who measured upper extremity muscle strength using an ordinal scale, found it to be correlated (p < .05) with both fine and gross motor coordination in 50 hemiparetic patients. 37 Dohrmann and Nowack also found a significant relationship (p < .005) between upper extremity weakness and decreased skill. 34 They concluded that the relationship was logical "because a weak upper extremity cannot accomplish skilled movements." 34(p376) Sjöström et al reported the maximal plantar-flexion torque of the affected lower extremity to be significantly correlated with the extremity's Fugl-Meyer motor score (r s = .66, p < .05) in 19 subjects with hemiparesis. 25 Bohannon found a correlation (r) of .631 between knee flexion force and movement speed in the lower extremity of stroke patients. 67 The variance in movement speed explained by the strength of four lower extremity muscle groups was 49.5%. Sheikh et al used a very gross four-level scale to document limb muscle function. 43 They reported significant correlations (p < .001) between activities-of-daily-living scores and upper limb function (-.487) and lower limb function (-.544). Logigian et al reported significant correlations (r = .34) between MMT grades and scores on the Barthel Index (an ordinal scale rating 10 self-care and mobility activities). 45 The MMT-Barthel Index correlations were significant on admission, on discharge, and across time. Wade and Hewer obtained similar findings. 44 Their ordinal strength measurement scores for hemiparetic patients were correlated with the Barthel Index scores initially (.749), at three weeks postinjury (.774), and at six months postinjury (.610). Feigenson et al described weakness in stroke patients as "mild," "moderate," or "severe." 31 They found such weakness to be one of the strongest predictors of patient placement upon discharge; dressing, feeding, and hygiene performance; and bowel and bladder control.
Weakness was also related to length of hospital stay. Hamrin et al reported positive and sometimes significant (8 of 24) correlations between elbow flexion-extension torques and the performance of hygiene, dressing, and household activities. 77 Fullerton et al studied the relationship between a host of predictor variables and mortality and functional outcome. 50 "Arm power" and "leg power," which were measured on a five-level ordinal scale, were among the significant predictors of functional outcome (p < .0001).
The performance of activities addressed directly by physical therapists has been correlated with measures of muscle strength. Primary among those activities is gait. Wade and Hewer found walking independence (ie, alone, with another person, unable) to be significantly correlated with ordinal measures of leg muscle strength (y = -.860). 44 Feigenson et al reported weakness to be a strong predictor of ambulation. 31 In addition to a study by Bohannon, 62 at least four other studies have documented a relationship between quantitative measurements of muscle strength and gait performance. Hamrin et al reported that isokinetic torques of the paretic and nonparetic knees were correlated with locomotion. 77 The correlations were higher on the paretic side (r s = .71-90) than on the nonparetic side (r s = .38-.67). Hamrin et al claimed that the highly significant correlations support the validity of the isokinetic strength test in the patients. In a more recent study, Bohannon found significant (p < .01) correlations between individual lower extremity paretic muscle group strength measurements and gait independence, distance, speed, and cadence (r s = .556-.840). The correlations were significant on initial assessment, final assessment, and across time. 85 In an earlier study, Bohannon investigated nine variables as potential explanations for four gait performance variables. 56 Although motor control and balance offered the best explanation of ambulatory capacity, normalized muscle strength of the paretic lower extremity was significantly correlated with gait velocity, cadence, appearance, and independence (r = .369-.511)-In 11 hemiparetic patients, Nakamura et al found knee extension torque (isokinetic torque at 30°, 90°, and 180°/ sec and isometric torque at 90° and 60° of flexion) to be significantly correlated with walking speed (r = .595-.847) and cadence (r = .609-.853). 79 They used stepwise regression to further analyze their data and found that isokinetic torque at 90°/sec explained 75.6% of the variance in gait speed and that isokinetic torque at 180°/sec explained 72.7% of the variance in gait cadence. In another study on patients with stroke, Nakamura found that "strength of the affected side was the primary determinant of walking speed and that the variance explained by it gradually increased with a period of training." 80(p111) Variance explained by strength of the affected side ranged from 25% at the initiation of gait training to 50% eight weeks later.
Among the other factors of specific interest to physical therapists and to which muscle strength measures are related are transfer performance, standing performance, rolling independence, and shoulder pain and shoulder-hand syndrome. In a study by Bohannon, the relationships between various paretic muscle group strengths and transfer independence were all significant on initial assessment (r s = .468-.643). 64 The correlations on final assessment and across time, although positive, were rarely significant (r s = .304-.477). The standing performance of 81 stroke patients was found by Bohannon to correlate significantly with the strength of six of seven muscle groups on both the paretic and nonparetic sides (r s = .255-.464). In an unpublished follow-up study, Bohannon confirmed the existence of significant correlations on initial assessment, final assessment, and across time. Although Bohannon, in a different study, did not find that muscle strength of the paretic side consistently explained rolling independence, he did find that the muscle strength of the nonparetic side explained rolling independence (r = .51-.75). 66 Chalsen et al concluded, from a study in which various potential causes of shoulder-hand syndrome were examined, that "weakness is a necessary but not sufficient cause for the development of shoulder-hand syndrome poststroke." 42(p137) Bohannon found shoulder abduction and lateral (external) rotation force production to be negatively and significantly correlated with shoulder pain in hemiparetic patients on initial assessment, on final assessment, and across assessment times (r s = -.375 to -.583). 65 He concluded that "patients with greater weakness may be prone to the development of pain because their muscles lack adequate strength to move the joint and prevent adhesive capsulitis." 65(p111) 
Conclusion
Muscle strength is by no means a variable of such great importance that it can be justified as a sole indicator of status, change, capacity, or outcome in patients with brain lesions. Substantial precedents and evidence exist, nevertheless, to support the appropriateness of muscle strength testing in these patients. Before accepting the direction of those opposed to such testing, the clinician should consider the information presented in this communication. Because considerable variance in patient performance remains unexplained by muscle strength, the search should continue for even better targets of measurement and treatment. 
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